Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Current Assets (2022 - 2026)

HeartSciences filings provide 5 years of Current Assets readings, the most recent being $5.1 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 40.5% to $5.1 million in Q1 2026 year-over-year; TTM through Jan 2026 was $5.1 million, a 40.5% increase, with the full-year FY2025 number at $2.2 million, down 70.47% from a year prior.
  • Current Assets hit $5.1 million in Q1 2026 for HeartSciences, up from $3.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $8.7 million in Q1 2024 to a low of $1.8 million in Q4 2023.
  • Median Current Assets over the past 5 years was $4.0 million (2022), compared with a mean of $4.2 million.
  • Biggest five-year swings in Current Assets: soared 213.93% in 2024 and later crashed 70.47% in 2025.
  • HeartSciences' Current Assets stood at $4.1 million in 2022, then tumbled by 56.09% to $1.8 million in 2023, then soared by 213.93% to $5.7 million in 2024, then tumbled by 33.32% to $3.8 million in 2025, then skyrocketed by 34.41% to $5.1 million in 2026.
  • The last three reported values for Current Assets were $5.1 million (Q1 2026), $3.8 million (Q4 2025), and $4.4 million (Q3 2025) per Business Quant data.